Pluri Inc Stock Today
| PLUR Stock | USD 4.61 0.06 1.28% |
PerformanceVery Weak
| Odds Of DistressVery High
|
Pluri is selling at 4.61 as of the 16th of March 2025; that is 1.28% down since the beginning of the trading day. The stock's lowest day price was 4.51. Pluri has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. The performance scores are derived for the period starting the 16th of December 2024 and ending today, the 16th of March 2025. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 30th of June 2003 | Category Healthcare | Classification Health Care |
Pluri Inc., a biotechnology company, focuses on the development of placenta-based cell therapy product candidates for the treatment of inflammatory, muscle injuries, and hematologic conditions. Pluri Inc. was incorporated in 2001 and is based in Haifa, Israel. The company has 7 M outstanding shares of which 30.04 K shares are at this time shorted by private and institutional investors with about 4.39 trading days to cover. More on Pluri Inc
Moving against Pluri Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Pluri Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| CEO President | Yaacov Yanay | |||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Composite, NASDAQ Health Care, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||
Pluri can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Pluri's financial leverage. It provides some insight into what part of Pluri's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||
Pluri Inc (PLUR) is traded on NASDAQ Exchange in USA. It is located in Building No. 5, Haifa, Israel, 3508409 and employs 106 people. Pluri is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 32.26 M. Pluri Inc conducts business under Biotechnology sector and is part of Health Care industry. The entity has 7 M outstanding shares of which 30.04 K shares are at this time shorted by private and institutional investors with about 4.39 trading days to cover.
Pluri Inc currently holds about 55.02 M in cash with (18.02 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.69.
Check Pluri Probability Of Bankruptcy
Ownership AllocationThe market capitalization of Pluri Inc is $32.26 Million. Pluri has significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Note, that even with negative profits, if the true value of the company is larger than the current market value, you may still be able to generate positive returns on investment in this company.
Check Pluri Ownership Details
Pluri Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Nelson, Van Denburg & Campbell Wealth Management Group, Llc | 2024-12-31 | 42.0 | |
| Jpmorgan Chase & Co | 2024-12-31 | 34.0 | |
| Winch Advisory Services, Llc | 2024-12-31 | 26.0 | |
| Tfc Financial Management | 2024-12-31 | 19.0 | |
| Global Wealth Strategies & Associates | 2024-12-31 | 8.0 | |
| Cbiz Investment Advisory Services, Llc | 2024-12-31 | 7.0 | |
| Ifp Advisors, Llc | 2024-12-31 | 1.0 | |
| Jane Street Group Llc | 2024-09-30 | 0.0 | |
| Qube Research & Technologies | 2024-09-30 | 0.0 | |
| Renaissance Technologies Corp | 2024-12-31 | 34 K | |
| Values First Advisors Inc | 2024-12-31 | 11.7 K |
Pluri Historical Income Statement
Pluri Stock Against Markets
Pluri Corporate Management
| Lior Raviv | Chief Officer | Profile | |
| Nimrod Zvi | Chief Officer | Profile | |
| John Dvor | Executive America | Profile | |
| Liat Zalts | Chief Treasurer | Profile | |
| Efrat LivneHadass | Vice Resources | Profile | |
| Orly Amiran | Chief Officer | Profile |
Additional Tools for Pluri Stock Analysis
When running Pluri's price analysis, check to measure Pluri's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pluri is operating at the current time. Most of Pluri's value examination focuses on studying past and present price action to predict the probability of Pluri's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pluri's price. Additionally, you may evaluate how the addition of Pluri to your portfolios can decrease your overall portfolio volatility.